These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 3137253

  • 1. Metoclopramide effect on serum prolactin LH and FSH in patients with polycystic ovary syndrome.
    Prelević GM, Würzburger MI, Perić LA.
    J Endocrinol Invest; 1988 Apr; 11(4):255-9. PubMed ID: 3137253
    [Abstract] [Full Text] [Related]

  • 2. Effects of dopamine and metoclopramide in polycystic ovary syndrome.
    Barnes RB, Mileikowsky GN, Cha KY, Spencer CA, Lobo RA.
    J Clin Endocrinol Metab; 1986 Aug; 63(2):506-9. PubMed ID: 3722335
    [Abstract] [Full Text] [Related]

  • 3. Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome.
    Prelević GM, Würzburger MI, Perić LA.
    J Endocrinol Invest; 1987 Aug; 10(4):389-95. PubMed ID: 3119696
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The hyperprolactinemic polycystic ovary syndrome may not be an distinct entity.
    Corenblum B, Taylor PJ.
    Fertil Steril; 1982 Nov; 38(5):549-52. PubMed ID: 6813147
    [Abstract] [Full Text] [Related]

  • 6. Dopamine might not be involved in the pathogenesis of polycystic ovary syndrome.
    Ferriani RA, Silva de Sá MF, Moura MD, Moreira AC, Gomes UA.
    Gynecol Endocrinol; 1989 Dec; 3(4):317-27. PubMed ID: 2516707
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prolactin response after gonadotropin-releasing hormone in the polycystic ovary syndrome.
    Shoupe D, Lobo RA.
    Fertil Steril; 1985 Apr; 43(4):549-53. PubMed ID: 3921411
    [Abstract] [Full Text] [Related]

  • 9. Prolactin levels in the polycystic ovary syndrome.
    Milewicz A.
    J Reprod Med; 1984 Mar; 29(3):193-6. PubMed ID: 6233421
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prolactin release in polycystic ovary.
    Falaschi P, del Pozo E, Rocco A, Toscano V, Petrangeli E, Pompei P, Frajese G.
    Obstet Gynecol; 1980 May; 55(5):579-82. PubMed ID: 6768043
    [Abstract] [Full Text] [Related]

  • 12. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
    Quigley ME, Sheehan KL, Casper RF, Yen SS.
    J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
    [Abstract] [Full Text] [Related]

  • 13. [Effects of bromocriptine and dopamine on pituitary hormone secretion in women].
    Masaoka K, Hosoya N, Mori T, Watanabe H, Ohkura T, Kumasaka T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Dec; 34(12):2155-62. PubMed ID: 6818310
    [Abstract] [Full Text] [Related]

  • 14. Hypothalamic dopaminergic tone and prolactin bioactivity in women with polycystic ovary syndrome.
    Hernández I, Parra A, Méndez I, Cabrera V, Cravioto MC, Mercado M, Díaz-Sánchez V, Larrea F.
    Arch Med Res; 2000 Dec; 31(2):216-22. PubMed ID: 10880731
    [Abstract] [Full Text] [Related]

  • 15. Central opioid activity in polycystic ovary syndrome with and without dopaminergic modulation.
    Barnes RB, Lobo RA.
    J Clin Endocrinol Metab; 1985 Oct; 61(4):779-82. PubMed ID: 3928677
    [Abstract] [Full Text] [Related]

  • 16. Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation.
    Quigley ME, Judd SJ, Gilliland GB, Yen SS.
    J Clin Endocrinol Metab; 1979 Apr; 48(4):718-20. PubMed ID: 429515
    [Abstract] [Full Text] [Related]

  • 17. Metoclopramide test in women with PCO syndrome after ovarian wedge resection.
    Vĕtr M, Talas M, Sobek A, Charamza J.
    Acta Univ Palacki Olomuc Fac Med; 1991 Apr; 130():257-64. PubMed ID: 1838876
    [Abstract] [Full Text] [Related]

  • 18. [Effects of bromocriptine on endocrine environment in the polycystic ovary syndrome].
    Huang HJ, Ishimaru T, Yamabe T.
    Nihon Naibunpi Gakkai Zasshi; 1988 Apr 20; 64(4):265-78. PubMed ID: 3136040
    [Abstract] [Full Text] [Related]

  • 19. Catecholamines and pituitary function. I. Effects of catecholamine synthesis inhibition and subsequent catecholamine infusion on gonadotropin and prolactin serum levels in normal cycling women and in women with hyperprolactinemic amenorrhea.
    Nicoletti I, Filipponi P, Sfrappini M, Fedeli L, Petrelli S, Gregorini G, Santeusanio F, Brunetti P.
    Horm Res; 1984 Apr 20; 19(3):158-70. PubMed ID: 6425187
    [Abstract] [Full Text] [Related]

  • 20. [Possible mechanisms of the interaction between gonadotropins and prolactin in an experimental hyperprolactinemia model].
    Tresguerres JA, Esquifino AI.
    Acta Physiol Lat Am; 1983 Apr 20; 33(3):257-74. PubMed ID: 6424409
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.